期刊文献+

血管内皮生长因子与急性呼吸窘迫综合征关系的研究 被引量:5

Relationship between vascular endothelial growth factor and acute respiratory distress syndrome
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)在急性呼吸窘迫综合征(ARDS)肺毛细血管通透性改变中的作用。方法测定30例ARDS患者、18例具有发生ARDS高危因素但未发生ARDS的患者、12例单纯机械通气患者以及11例正常对照者血浆VEGF、IL-6、sVEGFR-1、sVEGFR-2水平。结果ARDS患者血浆VEGF水平与未发生ARDS高危因素组和单纯机械通气组比较明显升高[(181.25±57.60)pg/mLvs(122.03±54.02)pg/mL和(82.33±36.38)pg/mL,P均<0.001];ARDS患者存活组VEGF水平与死亡组比较差异无统计学意义(P>0.05)。ARDS组血浆sVEGFR-1水平分别与未发生ARDS的高危因素组、单纯机械通气组及正常对照组比较差异无统计学意义(P>0.05),sVEGFR-2水平有低于正常对照组趋势,但无统计学意义。ARDS患者血浆IL-6水平较未发生ARDS的高危因素患者明显升高(P<0.001),且与IL-6水平呈正相关(r's=0.587,P<0.001)。结论升高的VEGF可能在ARDS早期发生中发挥了作用,IL-6可能参与此调节机制中。 Objective To discuss the effect of vascular endothelial growth factor( VEGF ) on the changes of pulmonary capillary permeability in the patients with acute respiratory distress syndrome ( ARDS ). Methods Plasma VEGF, sVEGFR - 1, sVEGFR - 2 and IL - 6 were measured with ELISA in 30 patients with ARDS, 18 high risk patients, 11 normal controls, and 12 ventilated control subjects. Resuits Compared with high risk patients and ventilated control subjects, plasma VEGF in the patients with ARDS was higher ( P 〈 0. 001). There were no statistical significances in VEGF between the survivals and the dead (P 〉 0.05 ). Compared with the three other groups, there was also no statistical significance in the plasma sVEGFR - 1 of patients with ARDS ( P 〉 0.05 ), but sVEGFR - 2 in patients with ARDS tended to be lower in comparison with control group. Compared with high risk patients, plasma IL -6 in the patients with ARDS was elevated, which correlated positively with VEGF (r's = 0. 587, P 〈 0. 001 ). Condusions Elevated VEGF levels would play a role in the development of ARDS.
出处 《中国急救医学》 CAS CSCD 北大核心 2007年第10期888-891,共4页 Chinese Journal of Critical Care Medicine
基金 宁夏教育厅基金项目(No2003-0125)
关键词 血管内皮生长因子 血管内皮生长因子受体 急性呼吸窘迫综合征 Vascular endothelial growth factor ( VEGF) sVEGFR - 1 and sVEGFR - 2 Acute respiratory distress syndrome (ARDS )
  • 相关文献

参考文献15

  • 1Jardin F, Fellahi JL, Beauchet A, et al. Improved prognosis of acute respiratory distress syndrome 15 years on [J]. Intensive Care Med, 1999, 25(9) : 936 -941.
  • 2Matthay MA, Zimmerman GA, Esmon C, et al. Future research direction in acute lung injury: summary of a national heart lung and blood institute working group [J]. Am J Respir Crit Care Med, 2003,167 (7) : 1027 - 1035.
  • 3Mura M, dos Santos CC, Stewart D, et al. Vascular endothelial growth factor and related molecules in acute lung injury [ J] J Appl Physiol, 2004, 97(5 ) : 1605 - 1617.
  • 4Schoch HJ, Fischer S, Marti HH. Hypoxia - induced vascular endothelial growth factor expression causes vascular leakage in the brain [J]. Brain, 2002, 125(11):2549- 2557.
  • 5Come J, Chupp G, Lee CG, et al. IL - 13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury [J]. J Clin Invest, 2000, 106(6) : 783 -791.
  • 6Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury [ J ]. Am J Respir Grit Care Med, 2002, 166(10) : 1332 -1337.
  • 7Thickett DR, Armstrong L, Christie SJ, et al. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome [J]. Am J Respir Crit Care Med, 2001, 164(9): 1601-1605.
  • 8Medford ARL, Millar AB. Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome: paradox or paradigm[J]. Thorax, 2006,61(7) : 621 -626.
  • 9姜恒,郭光金.VEGF及其受体的研究进展[J].局解手术学杂志,2004,13(2):126-127. 被引量:17
  • 10Bernard GR, Artigas A, Brigham KL, et al. The American - European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination [J]. Am J Respir Crit Care Med, 1994, 149(3) : 818 -824.

二级参考文献21

  • 1Vidal S, Lloyd RV, Moya L, et al. Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary[J]. J Histochem Cytochem,2002 50(4): 533- 540.
  • 2Toi M, Matsmnoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic imphcations[ J]. Lancet Oncol, 2001,2 ( 11 ) :667 - 673.
  • 3Brekken RA, Thorpe PE. Vascular endothelial growth factor and vascular targeting of solid tumors[J]. Anticancer Res, 2001,21(6B) :4221 - 4229.
  • 4Duyndam MC, Hilhorst MC, Sctduper HM, et al. Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts[J].Am J Pathol,2002,160(2) : 537 - 548.
  • 5Olofsson B, Jeltsch M, Eriksson U, et al. Current biology, of VEGF-B and VEGF-C[J]. Curr Opin Biotechnol, 1999, 10(6): 528 -535.
  • 6Wu LW, Mayo LD, Dunbar JD, et al. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation[J]. J Biol Chem,2000,275(7) : 5096 - 5103.
  • 7Lymboussaki A, Achen MG, Stacker SA, et al. Growth factors regulating lymphatic vessels[ J]. Curr Top Microbiol Immunol, 2000,25(1): 75-82.
  • 8Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenie mice expressing soluble VEGF reeeptor-3[J]. Nat Med,2001,7(2): 199-205.
  • 9Kanellis J, Paizis K, Cox AJ, et al. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression[J]. Kidney Int,2002,61(5) : 1696- 1706.
  • 10Duyndam MC,Hilhorst MC,Schluper HM,et al.Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts[J]. Am J Pathol,2002,160(2): 537-548.

共引文献16

同被引文献75

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部